Figure 3.
Impact of eGFR on (A) oral clearance allometrically scaled to a 70 kg adult and (B) AUC0–24 dose adjusted to 0.1 mg/kg/day. The geometric mean AUC0–24 dose adjusted to 0.1 mg/kg in historical hypertensive children is shown for comparison.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.